RCRoberto Colombo

Roberto Colombo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Roberto Colombo has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders

    by Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Marco Di Nicola, Roberto Colombo, Luigi Janiri, Soo-Jung Lee, Tae-Youn Jun, Sheng-Min Wang, Prakash S. Masand, et al.

    Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Marco Di Nicola, Roberto Colombo, Luigi Janiri, Soo-Jung Lee, Tae-Youn Jun, Sheng-Min Wang, Prakash S. Masand, Ashwin A. Patkar, Changsu Han, Chi-Un Pae, Alessandro Serretti. Clin Psychopharmacol Neurosci 2020;18:231-40. https://doi.org/10.9758/cpn.2020.18.2.231


    • 1 January 2010
      • Vol. 31  (1) , 117-21

    Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.

    by Enzo Emanuele, Roberto Colombo, Valentina Martinelli, Natascia Brondino, Mara Marini, Marianna Boso, Francesco Barale, Pierluigi Politi

    Previous studies have suggested that the endogeneous psychotomimetic molecule bufotenine (N-N-dimethyl-5-idroxytryptamine) may play a role in the pathogenesis of severe mental disorders. The potential association of bufotenine with the clinical features of autism and schizophrenia is not entirely understood. In this study, we measured urinary levels of bufotenine in subjects with autistic spectrum disorder (ASD), schizophrenia and healthy comparison subjects free of psychiatric symptoms. We also sought to assess whether urine concentrations of this molecule may be associated with the clinical characteristics of psychiatric patients. Urine bufotenine levels were measured using a high-performance liquid chromatography-mass spectrometry (HPLC-MS) assay in young adults with severe ASD (n=15), patients with schizophrenia (n=15), and healthy control subjects (n=18). The Vineland Adaptive Behavior Scale was used to measure adaptive behaviors in ASD individuals. The Brief Psychiatric Rating Scale (BPRS) was used for patients with schizophrenia. Urine bufotenine levels were significantly higher in ASD subjects (3.30 +/- 0.49 microg/L, p<0.05) and patients with schizophrenia (4.39 +/- 0.43 microg/L, p<0.001) compared with controls (1.53 +/- 0.30 microg/L). Among patients with ASD, there was a significant positive correlation between urine bufotenine and hyperactivity scores on the Vineland Adaptive Behavior Scale (r=0.479, p<0.05). No other associations were detected. Our results indicate that elevated urine levels of the endogeneous psychotomimetic molecule bufotenine may play a role in ASD and schizophrenia, and can be correlated with hyperactivity scores in autism.


  • From Apneic Spells to the Development of Hypertensive Hydrocephalus: A Case Report of Homocystinuria With Early Onset

    by Rosa Maria Cerbo, Rita Cabano, Giuseppina Lombardi, Lina Bollani, Roberto Colombo, Mauro Stronati

    Homocystinuria represents a group of hereditary metabolic disorders characterized by an accumulation of homocysteine in the serum and an increased excretion of homocysteine in the urine. The infantile form is severe: the main clinical findings are neurologic signs, associated with hematological signs and bone alterations. Immediate restoration of plasma amino acids is the primary goal and early diagnosis is crucial not to delay the onset of possible treatment. We report a case of homocystinuria with early onset: an initial symptomatology was undervalued by the pediatrician with a delay in diagnosis. Despite the therapy, the patient developed tetraventricular hydrocephalus requiring ventricular drainage. In conclusion, we want to remember the necessity to perform a complete metabolic workup in a patient with clinical manifestations suggestive for homocystinuria, and the importance of early recognition of the signs and symptoms of hypertensive hydrocephalus, a possible complication of this condition.